Jiangsu Yahong Meditech Co., Ltd.

The company is a company limited by the overall restructuring of the former Jiangsu Yahong Pharmaceutical Technology Co., Ltd., and was registered with the approval of the Jiangsu Taizhou Administration for Industry and Commerce on March 16, 2010. The company's shares were listed and traded on the Shanghai Stock Exchange on January 7, 2022. The company is a global specialty innovative pharmaceutical company focusing on urogenital tumors and other major diseases. It is a leading international pharmaceutical company integrating R&D, production and sales in the field of treatment, providing the best integrated diagnosis and treatment solutions for patients in China and around the world. Main products: APL-1702, APL-1706, APL-1202, APL-1501, APLD-2304, AT-014, AT-020,, APL-2302, AT-017,, AT-018,,. AT-021 APL-1202 APL-1401 APL-2301